IRB Closure Application
04.17.2018
Page 3 of 4
3. Were any unanticipated problems, serious adverse events, complaints, or other events requiring
prompt reporting to the IRB encountered since the last continuing IRB review that were not
previously reported to the IRB?
No
Yes. If yes, please explain.
4. Conflict of Interest
a. Have any conflicts of interest been identified that have not already been disclosed to the SPCC IRB? Do
any of the participating study investigators or other key personnel (or their immediate family/significant
other) have a financial or intellectual interest in, or are receiving compensation from, the sponsor or the
drugs, devices or technologies used in this research? If additional conflicts have been identified, explain
the conflict and any mitigating measures.
No
Yes. If yes, please explain.
b. Do you have or anticipate (within the year) any financial relationships (e.g., consulting, speaking,
advisory boards, patents, equity, options) that could be perceived to overlap or present a conflict of
interest with the current proposal?
No
Yes. If yes, please explain.